• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

    20.48 -0.09 (-0.46%)
    Streaming Delayed Price Updated: 12:47 PM EDT, Apr 8, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 171,941
    Open 20.68
    Bid (Size) 20.45 (400)
    Ask (Size) 20.50 (100)
    Prev. Close 20.58
    Today's Range 20.18 - 21.07
    52wk Range 17.03 - 31.26
    Shares Outstanding 48,081,433
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference
    Via ACCESS Newswire
    News headline image
    1 Small-Cap Stock Worth Your Attention and 2 That Underwhelm
    Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th... 
    Via StockStory

    Performance

    YTD
    -22.6%
    -22.6%
    1 Month
    +6.6%
    +6.6%
    3 Month
    -25.8%
    -25.8%
    6 Month
    -20.7%
    -20.7%
    1 Year
    -18.1%
    -18.1%

    More News

    Read More
    News headline image
    3 of Wall Street’s Favorite Stocks We Think Twice About
    Via StockStory
    News headline image
    NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know
    Via StockStory
    Topics Economy Stocks
    Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Plummets After Q4 Earnings Miss Estimates ↗
    Via Chartmill
    Topics Earnings
    News headline image
    AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know
    Via StockStory
    Topics Economy
    News headline image
    Generic Pharmaceuticals Stocks Q4 Highlights: Amphastar Pharmaceuticals (NASDAQ:AMPH)
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Why Amphastar Pharmaceuticals (AMPH) Shares Are Plunging Today
    Via StockStory
    Topics Economy
    News headline image
    Amphastar (AMPH) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings Supply Chain
    News headline image
    Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 CY2025 Revenue Estimates, Stock Drops 11.7%
    Via StockStory
    Topics Artificial Intelligence Supply Chain
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals (AMPH) Reports Earnings Tomorrow: What To Expect
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Amphastar Announces FDA Approval for Ipratropium Bromide HFA
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026
    Via ACCESS Newswire
    News headline image
    1 Value Stock on Our Watchlist and 2 We Turn Down
    Via StockStory
    Topics Retirement
    News headline image
    Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know
    Via StockStory
    Topics Economy
    News headline image
    3 Cash-Producing Stocks We Keep Off Our Radar
    Via StockStory
    News headline image
    3 Stocks Under $50 with Warning Signs
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Why Amphastar Pharmaceuticals (AMPH) Stock Is Nosediving
    Via StockStory
    News headline image
    2 Reasons to Avoid AMPH and 1 Stock to Buy Instead
    Via StockStory
    Topics Stocks Supply Chain
    News headline image
    1 Profitable Stock Worth Your Attention and 2 Facing Headwinds
    Via StockStory
    News headline image
    Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today
    Via StockStory
    News headline image
    Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound
    Via ACCESS Newswire
    News headline image
    3 Low-Volatility Stocks We Find Risky
    Via StockStory

    Frequently Asked Questions

    Is Amphastar Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Amphastar Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Amphastar Pharmaceuticals, Inc. - Common Stock trade on?
    Amphastar Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock is AMPH on the Nasdaq Stock Market
    What is the current price of Amphastar Pharmaceuticals, Inc. - Common Stock?
    The current price of Amphastar Pharmaceuticals, Inc. - Common Stock is 20.48
    When was Amphastar Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Amphastar Pharmaceuticals, Inc. - Common Stock was at 04/08/26 12:47 PM ET
    What is the market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock is 984.95M
    How many shares of Amphastar Pharmaceuticals, Inc. - Common Stock are outstanding?
    Amphastar Pharmaceuticals, Inc. - Common Stock has 985M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.